125 Cambridgepark Drive Cambridge, MA 02140 +1 877.848.9903

Challenges are an inevitability when building a drug portfolio in the rare disease space, and patient finding is no doubt chief among them. Clinical trial recruitment is highly capital intensive,...

Though it’s not often discussed, often the most difficult aspect of bringing a drug to market is finding the right patient population. This is especially true with rare diseases, where patients...

Our own Julie Gubitosa and Graham Jones accompanied by Keith R. McCrae, MD of the Cleveland Clinic and Jennifer Beachell, Tricia Gooljarsingh PhD and Mary Lee Tjoa of Momenta Pharmaceutical,...

Select Category

July 13, 2021

John Garcia of Alnylam Discusses Finding Patients With Rare Disease

0

Challenges are an inevitability when building a drug portfolio in the rare disease space, and patient finding is no doubt chief among them. Clinical trial recruitment is highly capital intensive,...

April 21, 2021

Using Non-Traditional Data to Unlock Disease Insights & Improve Outcomes

0

Though it’s not often discussed, often the most difficult aspect of bringing a drug to market is finding the right patient population. This is especially true with rare diseases, where patients...

January 19, 2021

IPM.ai and Momenta Featured at the 62nd Annual Meeting of the American Society...

0

Our own Julie Gubitosa and Graham Jones accompanied by Keith R. McCrae, MD of the Cleveland Clinic and Jennifer Beachell, Tricia Gooljarsingh PhD and Mary Lee Tjoa of Momenta Pharmaceutical,...

October 12, 2020

Using ML and AI to Infer HCP Specialties

0

Specialty Physician Identification: Your Best Targets Could Be Hiding In Plain Sight and You May Be Missing Them

October 11, 2020

Swoop Partners With IPM.ai for Pharmaceutical Ad Optimization

0

Real World Data and Social Determinants of Health can now be used for precision cross-channel pharmaceutical marketing campaigns

February 25, 2020

Artificial Intelligence Modeling Techniques to Uncover Patient Events

0

High Noise Healthcare Data Environments Are a Prime Candidate for Advanced Technologies